NanoViricides annual meeting adjourned on redomicile proposal; directors re-elected, Diwan grant approved

NANOVIRICIDES, INC.

Directors Rokita (5.99M for), Jawadekar (5.95M for), Zucker (6.05M for) re-elected.
Approved 10,204 Series A Preferred Shares grant to President Anil Diwan (5.72M for, 1.01M against).
Ratified EisnerAmper as auditor for FY2023 (9.26M for, 88k against).
Redomicile to Delaware proposal did not pass; meeting adjourned to Feb 7, 2023 for further voting.
Quorum of 57% of voting shares was present at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.